Ten years of HER2-directed therapy: still questions after all these years

MeSH terms

• Antibodies, Monoclonal / therapeutic use*
• Antibodies, Monoclonal, Humanized
• Antineoplastic Agents / administration & dosage
• Antineoplastic Agents / pharmacology
• Antineoplastic Agents / therapeutic use*
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Breast Neoplasms / drug therapy*
• Breast Neoplasms / genetics
• Capecitabine
• Clinical Trials, Phase III as Topic
• Deoxycytidine / administration & dosage
• Deoxycytidine / analogs & derivatives
• Disease-Free Survival
• Drug Delivery Systems*
• Drug Resistance, Neoplasm
• ErbB Receptors / antagonists & inhibitors
• Female
• Fluorouracil / administration & dosage
• Fluorouracil / analogs & derivatives
• Forecasting
• Humans
• Lapatinib
• Neoplasm Proteins / antagonists & inhibitors*
• Protein Kinase Inhibitors / administration & dosage
• Protein Kinase Inhibitors / pharmacology
• Protein Kinase Inhibitors / therapeutic use*
• Quinazolines / administration & dosage
• Randomized Controlled Trials as Topic
• Receptor, ErbB-2 / antagonists & inhibitors*
• Trastuzumab